Patricia Harnden

FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer

Darren C. Tomlinson, Omer Baldo, Patricia Harnden et al. · The Journal of Pathology · 2007 · 355 citations · Full text

Pathology, Fgfr-targeted Therapy, Tumor Biology +16

Genetic and Epigenetic Analysis of von Hippel-Lindau ( <i>VHL</i> ) Gene Alterations and Relationship with Clinical Variables in Sporadic Renal Cancer

Rosamonde E. Banks, Prasanna Tirukonda, Claire Taylor et al. · Cancer Research · 2006 · 272 citations

The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis — Preliminary findings

Rosamonde E. Banks, Michael J. Dünn, Darryl Pappin et al. · Electrophoresis · 1999 · 252 citations

Proteomic changes in renal cancer and co‐ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect

Richard D. Unwin, Rachel A. Craven, Patricia Harnden et al. · PROTEOMICS · 2003 · 248 citations

Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer

Fiona M. Platt, Carolyn D. Hurst, Claire Taylor et al. · Clinical Cancer Research · 2009 · 243 citations